124 related articles for article (PubMed ID: 8850378)
1. Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.
Bartels GL; Remme WJ; den Hartog FR; Wielenga RP; Kruijssen DA
Cardiovasc Drugs Ther; 1995 Dec; 9(6):749-53. PubMed ID: 8850378
[TBL] [Abstract][Full Text] [Related]
2. Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?
Bartels GL; Remme WJ; Holwerda KJ; Kruijssen DA
Eur Heart J; 1996 Mar; 17(3):414-20. PubMed ID: 8737216
[TBL] [Abstract][Full Text] [Related]
3. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
4. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
Bartels GL; Remme WJ; Pillay M; Schönfeld DH; Kruijssen DA
Am J Cardiol; 1994 Jul; 74(2):125-30. PubMed ID: 8023775
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
7. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
8. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Borer JS; Fox K; Jaillon P; Lerebours G;
Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
[TBL] [Abstract][Full Text] [Related]
9. Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers.
Meluzín J; Zeman K; Stĕtka F; Simek P
J Cardiovasc Pharmacol; 1992 Dec; 20(6):864-9. PubMed ID: 1282586
[TBL] [Abstract][Full Text] [Related]
10. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction.
Caponnetto S; Canale C; Masperone MA; Terracchini V; Valentini G; Brunelli C
Eur Heart J; 1994 Sep; 15(9):1267-73. PubMed ID: 7982429
[TBL] [Abstract][Full Text] [Related]
12. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
[TBL] [Abstract][Full Text] [Related]
13. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
[TBL] [Abstract][Full Text] [Related]
14. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
15. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
16. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
[TBL] [Abstract][Full Text] [Related]
17. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
Glasser SP; West TW
Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788
[TBL] [Abstract][Full Text] [Related]
18. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial.
Koenig W; Höher M
J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363
[TBL] [Abstract][Full Text] [Related]
19. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
Winsor T; Berger HJ
Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
[TBL] [Abstract][Full Text] [Related]
20. L-propionylcarnitine does not affect myocardial metabolic or functional response to chronotropic and inotropic stimulation after repetitive ischemia in anesthetized pigs.
Duncker DJ; Sassen LM; Bartels GL; van Meegen JR; McFalls EO; Krams R; Bezstarosti K; Lamers JM; Verdouw PD
J Cardiovasc Pharmacol; 1993 Sep; 22(3):488-98. PubMed ID: 7504143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
